Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-15

Clinical Trial Update: Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Botulax to Botox for moderate to severe crow's feet lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)
  • Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Crow's Feet Lines | Phase 3 | Status: COMPLETED